Azulfidine Related Clinical Trials
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis [Suspended]
Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis [Completed]
Effects of Sulfasalazine on BOLD Response to Alcohol Cues [Completed]
TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis [Active, not recruiting]
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma [Completed]
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study [Terminated]
Study of Sulfasalazine in Treating Painful Neuropathy [Recruiting]
Sulfasalazine and Endothelial Function [Completed]
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS) [Recruiting]
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain [Completed]
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis [Completed]
An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects [Recruiting]
Treatments Against RA and Effect on FDG-PET/CT [Not yet recruiting]
A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine [Completed]
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy [Completed]
Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial [Completed]
Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine [Completed]
Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) [Completed]
Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) [Recruiting]
Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis [Completed]
Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region [Completed]
AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment [Completed]
Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects [Completed]
Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time. [Completed]
Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity [Recruiting]
Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis [Enrolling by invitation]
Very Early Versus Delayed Etanercept in Patients With RA [Recruiting]
Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED) [Terminated]
Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) [Completed]
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) [Completed]
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis [Active, not recruiting]
An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement [Recruiting]
RICE: Remission by Intra-articular Injection Plus CErtolizumab [Recruiting]
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection [Completed]
Monoclonal Antibody Treatment of Crohn's Disease [Completed]
Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis [Completed]
To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) [Completed]
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) [Recruiting]
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Active, not recruiting]
Curcumin in Pediatric Inflammatory Bowel Disease [Completed]
Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy [Completed]
16.0040 Ankylosing Spondylitis Study [Completed]
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy [Completed]
To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Completed]
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. [Completed]
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) [Completed]
Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis [Completed]
Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction [Recruiting]
Extension Study Evaluating Etanercept in Ankylosing Spondylitis [Completed]
A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate and/or Other DMARDS in Patients With Rheumatoid Arthritis [Recruiting]
A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis [Active, not recruiting]
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis [Completed]
|